English  |  正體中文  |  简体中文  |  2856704  
???header.visitor??? :  53764552    ???header.onlineuser??? :  2080
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"keng h y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-14 of 14  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-09-15T01:09:54Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Chia-Chi Lin; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2022-09-15T01:09:51Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Chia-Chi Lin; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H.
國立成功大學 2022 An Embarrassingly Simple Rule-based Visiting Circulation Approach to Trip Destination Prediction Tu, E.-S.;Chen, Y.-H.;Liu, E.-C.;Keng, H.-Y.;Li, C.-T.
臺大學術典藏 2021-10-14T02:46:15Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.; Hsu C.-H.; CHAO-YUAN HUANG; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:33Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏 2021-09-01T01:54:27Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Lin C.-C.; Pu Y.-S.; Hsu C.-H.; Keng H.-Y.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏 2021-03-04T02:36:02Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2021-02-02T00:46:57Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Tsai Y.-C.;Huang K.-H.;Cheng A.-L.;Yeong-Shiau Pu; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; YEONG-SHIAU PU
臺大學術典藏 2021-02-02T00:46:51Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Lin C.-C.; YEONG-SHIAU PU; Hsu C.-H.; Keng H.-Y.; Cheng A.-L.; Yang C.-H.
臺大學術典藏 2021-01-28T02:03:54Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S.
臺大學術典藏 2020-05-26T09:27:21Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Chih-Hsin Yang;Cheng A.-L;Keng H.-Y;Hsu C.-H;Pu Y.-S;Lin C.-C; Lin C.-C; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; CHIH-HSIN YANG
臺大學術典藏 2020-05-26T09:27:21Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Chih-Hsin Yang;Cheng A.-L;Keng H.-Y;Hsu C.-H;Pu Y.-S;Lin C.-C; Lin C.-C; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; CHIH-HSIN YANG
臺大學術典藏 2020-05-25T07:35:33Z Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study Chia-Chi Lin; Hsu C.-H; Huang C.-Y; Keng H.-Y; Tsai Y.-C; Huang K.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:30Z Acute encephalopathy following arsenic trioxide for metastatic urothelial carcinoma Chia-Chi Lin; Pu Y.-S; Hsu C.-H; Keng H.-Y; Cheng A.-L; Yang C.-H.

Showing items 1-14 of 14  (1 Page(s) Totally)
1 
View [10|25|50] records per page